Trial intelligence / Profile preview

Baseline Oral Health Study

NCT04954313Phase 4Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Sep 2021
Primary completion
Feb 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Change in Oral Health Measures at 360 days, Association Between Changes in Oral Health (Probing Depth) and Changes in Systemic Health (HbA1c) at 360 days and 1 more. Started Sep 2021; status: completed.

Beyond the preview

Go deeper on NCT04954313.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04954313.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call